Vascular - Critical Limb Ischemia (CLI) | |
|---|---|
| Study Name | Principal Investigator |
| LF-CA-PR-53 – Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia:The PROMISE III Trial. Read more. |
Kevin Herman, MD |
| LIFE-BTK – Pivotal Investigation of Safety and Efficacy of BRS Treatment (Below the Knee) Randomized Controlled Trial. Read more. |
John Rundback, MD |
| MOTIV-BTK-RCT – A Prospective, Multicenter, Single Blind, Randomized Controlled Trial Evaluation the Safety and Effectiveness of the MOTIV Sirolimus-Eluting Bioresorbable Vascular Scaffold Compared with Plain Balloon Angioplasty for the Treatment of Infrapopliteal Lesions. Read more. |
John Rundback, MD |
Vascular - Native Arteriovenous Dialysis Fistulae (AVF) | |
| Study Name | Principal Investigator |
| APV-IN.PACT AV Access – A randomized Study of IN.PACT™ AV Access Paclitaxel-Coated Percutaneous Transluminal Angioplasty (PTA) Balloon vs. Standard PTA for the Treatment of Obstructive Lesions in the Native Arteriovenous Dialysis Fistulae (AVF). Read more. |
John Rundback, MD |
Vascular - Peripheral Artery Disease (PAD) | |
| Study Name | Principal Investigator |
| OSPREY ILIAC – TIS2015-01 – Occlusive/Stenotic Peripheral artery Revascularization Study for Common and/or External Iliac Artery Using the Misago® RX Self-expanding Peripheral Stent. Read more. |
John Rundback, MD |
| SELUTION4SFA – A Prospective Randomized Multicenter Single-Blinded Study to Assess the Safety and Efficacy of the SELUTION SLR™ 018 Drug Eluting Balloon in the Treatment of Subjects with Femopopliteal Artery Lesions. Read more. |
John Rundback, MD |
